Association between the primary biliary cirrhosis specific anti-sp100 antibodies and recurrent urinary tract infection. (Q54513858)

30 May 2018

title

Association between the primary biliary cirrhosis specific anti-sp100 antibodies and recurrent urinary tract infection. (English)

1 reference

30 May 2018

primary biliary cholangitis

1 reference

0 references

author

Dimitrios P. Bogdanos

1

1 reference

30 May 2018

author name string

H Baum

2

1 reference

30 May 2018

P Butler

3

1 reference

30 May 2018

E I Rigopoulou

4

1 reference

30 May 2018

E T Davies

5

1 reference

30 May 2018

Y Ma

6

1 reference

30 May 2018

A K Burroughs

7

1 reference

30 May 2018

D Vergani

8

1 reference

30 May 2018

publication date

1 November 2003

1 reference

30 May 2018

Digestive and Liver Disease

published in

1 reference

30 May 2018

volume

35

1 reference

30 May 2018

issue

11

1 reference

30 May 2018

page(s)

801-805

1 reference

30 May 2018

Mitochondrial antigens, molecular mimicry and autoimmune disease

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2803%2900466-3

7 January 2021

PBC: an infectious disease?

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2803%2900466-3

7 January 2021

HLA DRB4 0101-restricted immunodominant T cell autoepitope of pyruvate dehydrogenase complex in primary biliary cirrhosis: evidence of molecular mimicry in human autoimmune diseases

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2803%2900466-3

7 January 2021

Antibodies against the COOH-terminal region of E. coli ClpP protease in patients with primary biliary cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2803%2900466-3

7 January 2021

Antibodies to Clp protease in primary biliary cirrhosis: possible role of a mimicking T-cell epitope

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2803%2900466-3

7 January 2021

Antibodies against homologous microbial caseinolytic proteases P characterise primary biliary cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2803%2900466-3

7 January 2021

Primary biliary cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2803%2900466-3

7 January 2021

Primary biliary cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2803%2900466-3

7 January 2021

Antimitochondrial and other autoantibodies

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2803%2900466-3

7 January 2021

Bacteriuria and primary biliary cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2803%2900466-3

7 January 2021

Natural history of bacteriuria in women with primary biliary cirrhosis and the effect of antimicrobial therapy in symptomatic and asymptomatic groups

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2803%2900466-3

7 January 2021

M2 mitochondrial antibodies and urinary rough mutant bacteria in patients with primary biliary cirrhosis and in patients with recurrent bacteriuria.

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2803%2900466-3

7 January 2021

Significant bacteriuria has prognostic significance in primary biliary cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2803%2900466-3

7 January 2021

Risk factors for primary biliary cirrhosis in a cohort of patients from the united states

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2803%2900466-3

7 January 2021

Nuclear envelope protein autoantibodies in primary biliary cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2803%2900466-3

7 January 2021

Autoantibodies against "nuclear dots" in primary biliary cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2803%2900466-3

7 January 2021

Autoantibodies against a 210 kDa glycoprotein of the nuclear pore complex as a prognostic marker in patients with primary biliary cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2803%2900466-3

7 January 2021

Autoantibodies against nuclear pore complexes are associated with more active and severe liver disease in primary biliary cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2803%2900466-3

7 January 2021

Characterization and clinical impact of antinuclear antibodies in primary biliary cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2803%2900466-3

7 January 2021

Positive markers in AMA-negative PBC

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2803%2900466-3

7 January 2021

Autoimmune disease and molecular mimicry: an hypothesis

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2803%2900466-3

7 January 2021

Molecular mimicry in liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2803%2900466-3

7 January 2021

Bile duct cell apoptosis: a rare event in primary biliary cirrhosis?

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2803%2900466-3

7 January 2021

Primary biliary cirrhosis: modalities of injury and death in biliary epithelium

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2803%2900466-3

7 January 2021

Role of apoptosis in development of primary biliary cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2803%2900466-3

7 January 2021

Molecular mimicry of mitochondrial and nuclear autoantigens in primary biliary cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2803%2900466-3

7 January 2021

Molecular mimicry and autoimmune liver disease: virtuous intentions, malign consequences

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2803%2900466-3

7 January 2021

Virus, liver and autoimmunity.

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2803%2900466-3

7 January 2021

Molecular mimicry and primary biliary cirrhosis: premises not promises

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2803%2900466-3

7 January 2021

10.1016/S1590-8658(03)00466-3

Identifiers

DOI

1 reference

30 May 2018

1 reference

30 May 2018